425: Strive & Semler Scientific Merger Update

Strive Inc. board member Pierre Rochard reposts communication regarding the proposed business combination with Semler Scientific Inc.

Summary

• A communication was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on September 25, 2025.
• The communication pertains to Strive's proposed business combination with Semler Scientific, Inc.
• It includes forward-looking statements regarding the transaction's outlook, expected strategic and financial benefits, timing of closing, and ability to integrate the combined businesses.
• The document emphasizes that these forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus when they become available, as they will contain important information about the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement for a proposed merger, providing a balanced view of potential benefits and extensive risks. It is neither overtly positive nor negative, focusing on regulatory compliance and risk disclosure.

Positives

• Anticipated strategic benefits of the proposed transaction.
• Expected financial benefits of the proposed transaction.
• Anticipated cost savings and strategic gains from the combined entity.

Negatives

• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both of Strive and Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

Strive and Semler Scientific anticipate strategic and financial benefits from the proposed business combination, including expected impacts on the combined company's future financial performance, and aim for a timely closing and successful integration of businesses. However, these are forward-looking statements subject to significant risks and uncertainties.

Management Comments

• Pierre Rochard, Board Member of Strive, Inc., reposted the communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

The filing mentions risks associated with 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets,' suggesting that the combined entity or at least one of the companies has exposure or plans to engage with digital assets, aligning with a growing trend of corporate adoption of digital asset strategies.

Comparison to Industry Standards

• No specific comparable companies, projects, or results are mentioned in the filing to assess against global benchmarks.

Corporate Governance

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders: Potential dilution for Strive shareholders due to new stock issuance.
• Customers: Potential adverse reactions or changes to business relationships.
• Employees: Potential changes to employee relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.

Key Dates

Recommendation

The filing details a proposed business combination between Strive and Semler Scientific, which is inherently price-sensitive. However, it is primarily a cautionary statement outlining numerous risks associated with the merger, including integration difficulties, potential delays, cost overruns, dilution, and market reactions. Without specific financial terms or updated performance metrics, a 'hold' recommendation is appropriate, advising investors to await further details and the definitive proxy materials before making significant investment decisions, while acknowledging the strategic intent.

Keywords

Strive Inc., Semler Scientific, Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance, Stockholder Approval